Clinical trials
Musculoskeletal Diseases trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 3 |
| Recruiting | 2 |
| Enrolling by invitation | 2 |
| Unknown status | 2 |
| Withdrawn | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| QED Therapeutics, a BridgeBio company | 3 |
| Vastra Gotaland Region | 3 |
| AbbVie | 2 |
| Catabasis Pharmaceuticals | 2 |
| Göteborg University | 2 |
| Lund University | 2 |
| PTC Therapeutics | 2 |
| Amgen | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
| Karolinska Institutet | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Musculoskeletal Diseases | 22 |
| Genetic Diseases, Inborn | 6 |
| Neuromuscular Diseases | 5 |
| Bone Diseases | 4 |
| Muscular Dystrophies | 4 |
| Muscular Dystrophy, Duchenne | 4 |
| Arthritis | 3 |
| Dwarfism | 3 |
| Joint Diseases | 3 |
| Mucopolysaccharidosis IV | 3 |
Trials
Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.